Carzelesin
Get a Quick Quote Now
Select Packaging
Product Description
Product
Carzelesin
CAS
119813-10-4
Formula
C41H37ClN6O5
Synonym
Carzelesin, 119813-10-4, NSC-619029, U-80244, [(8S)-8-(chloromethyl)-6-[5-[[6-(diethylamino)-1-benzofuran-2-carbonyl]amino]-1H-indole-2-carbonyl]-1-methyl-7,8-dihydro-3H-pyrrolo[3,2-e]indol-4-yl] N-phenylcarbamate, 668UF07O1P, Carzelesin (USAN/INN), Carzelesin [USAN:INN], UNII-668UF07O1P, NSC 619029, CARZELESIN [INN], CARZELESIN [USAN], U80244; U 80244, U 80244, CHEMBL32911, SCHEMBL7183293, DTXSID30152602, N-(2-(((S)-1-(Chloromethyl)-1,6-dihydro-5-hydroxy-8-methylbenzo(1,2-b:4,3-b')dipyrrol-3(2H)-yl)carbonyl)indol-5-yl)-6-(diethylamino)-2-benzofurancarboxamide carbanilate (ester), D03416, Q27263977, [8-(chloromethyl)-6-[5-[[6-(diethylamino)-1-benzofuran-2-carbonyl]amino]-1H-indole-2-carbonyl]-1-methyl-7,8-dihydro-3H-pyrrolo[3,2-e]indol-4-yl] N-phenylcarbamate, 2-Benzofurancarboxamide, N-(2-((1-(chloromethyl)-1,6-dihydro-8-methyl-5-(((phenylamino)carbonyl)oxy)benzo(1,2-b:4,3-b')dipyrrol-3(2H)-yl)carbonyl)-1H-idnol-5-yl)-6-(diethylamino)-, (S)-, 2-Benzofurancarboxamide, N-(2-((1-(chloromethyl)-1,6-dihydro-8-methyl-5-(((phenylamino)carbonyl)oxy)benzo(1,2-b:4,3-b')dipyrrol-3(2H)-yl)carbonyl)-1H-indol-5-yl)-6-(diethylamino)-, (S)-; U-80244
Typical Product Specifications
Assay/Purity
Typically NLT 98%
Chemical Structure
Notes
Carzelesin is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
Carzelesin
Product Description
Product
Carzelesin
CAS
119813-10-4
Formula
C41H37ClN6O5
Synonym
Carzelesin, 119813-10-4, NSC-619029, U-80244, [(8S)-8-(chloromethyl)-6-[5-[[6-(diethylamino)-1-benzofuran-2-carbonyl]amino]-1H-indole-2-carbonyl]-1-methyl-7,8-dihydro-3H-pyrrolo[3,2-e]indol-4-yl] N-phenylcarbamate, 668UF07O1P, Carzelesin (USAN/INN), Carzelesin [USAN:INN], UNII-668UF07O1P, NSC 619029, CARZELESIN [INN], CARZELESIN [USAN], U80244; U 80244, U 80244, CHEMBL32911, SCHEMBL7183293, DTXSID30152602, N-(2-(((S)-1-(Chloromethyl)-1,6-dihydro-5-hydroxy-8-methylbenzo(1,2-b:4,3-b')dipyrrol-3(2H)-yl)carbonyl)indol-5-yl)-6-(diethylamino)-2-benzofurancarboxamide carbanilate (ester), D03416, Q27263977, [8-(chloromethyl)-6-[5-[[6-(diethylamino)-1-benzofuran-2-carbonyl]amino]-1H-indole-2-carbonyl]-1-methyl-7,8-dihydro-3H-pyrrolo[3,2-e]indol-4-yl] N-phenylcarbamate, 2-Benzofurancarboxamide, N-(2-((1-(chloromethyl)-1,6-dihydro-8-methyl-5-(((phenylamino)carbonyl)oxy)benzo(1,2-b:4,3-b')dipyrrol-3(2H)-yl)carbonyl)-1H-idnol-5-yl)-6-(diethylamino)-, (S)-, 2-Benzofurancarboxamide, N-(2-((1-(chloromethyl)-1,6-dihydro-8-methyl-5-(((phenylamino)carbonyl)oxy)benzo(1,2-b:4,3-b')dipyrrol-3(2H)-yl)carbonyl)-1H-indol-5-yl)-6-(diethylamino)-, (S)-; U-80244
Typical Product Specifications
Assay/Purity
Typically NLT 98%
Chemical Structure
Notes
Carzelesin is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
